Auvi-Q Approval History 
- FDA approved: Yes (First approved August 10th, 2012)
- Brand name: Auvi-Q
- Generic name: epinephrine
- Company: Sanofi
- Treatment for: Anaphylaxis, Allergic Reactions
Auvi-Q (epinephrine injection) is a voice-guided epinephrine auto-injector for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis.
FDA Approval History for Auvi-Q
| Date | Article |
|---|---|
| Aug 13, 2012 |  Sanofi Announces FDA Approval for Auvi-Q, First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies |
See also...
Auvi-Q (epinephrine) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
